Skip to main content
BMJ Open logoLink to BMJ Open
. 2020 Oct 21;10(10):e037017. doi: 10.1136/bmjopen-2020-037017

Living with a left ventricular assist device: psychological burden and coping: protocol for a cross-sectional and longitudinal qualitative study

Michael Levelink 1,, Harald Christian Eichstaedt 2, Sven Meyer 3, Anna Levke Brütt 1
PMCID: PMC7580038  PMID: 33087369

Abstract

Introduction

Due to technological progress and persistent shortage of donor hearts, left ventricular assist devices (LVADs) have become established in the treatment of advanced heart failure. Accordingly, more patients live with LVADs for prolonged periods. Related research focused primarily on clinical issues and little is known about psychosocial aspects of living with an LVAD. This study aims to explore psychological burden and coping following LVAD implantation.

Methods and analysis

An exploratory qualitative study with cross-sectional and longitudinal elements will be carried out. At least 18 patients with LVAD who have the device implanted from a few weeks to more than 3 years will be interviewed in the cross-sectional component using an interview guide. A subsample of patients who live with the LVAD for up to 3 months when recruited will be interviewed two additional times in the following year. The cross-sectional interviews will be analysed using an inductive qualitative content analysis to describe psychological burden, coping resources and behaviour from the patient’s perspective. Based on the findings, the longitudinal interviews will be analysed with a deductive content analysis to explore psychological adjustment during the first year after implantation. The findings will provide a deeper understanding of the complex and specific situation of patients with LVAD and of psychological adjustment to living with a life-sustaining implant. This can help clinicians in considering individual aspects to promote patient outcomes and is the basis for further research on healthcare interventions or technical solutions to reduce burden and for developing rehabilitation measures to promote psychosocial outcomes.

Ethics and dissemination

Ethical approval was obtained from the ethics committee of the School of Medicine and Health Sciences at the University of Oldenburg (2019-023). Study findings will be disseminated at national and international conferences and through peer-reviewed journals.

Trial registration number

German Clinical Trials Register (DRKS00016883).

Keywords: heart failure, qualitative research, rehabilitation medicine


Strengths and limitations of this study.

  • The qualitative design allows developing an in-depth understanding of how the patients coping and psychological adjustment to living with a left ventricular assist device.

  • Patients with diverse nature and extent of experiences will be recruited in a purposeful sampling.

  • This is the first longitudinal study investigating psychological adjustment to a dependable medical implant.

  • Involving patients and practitioners in preparation and analysis ensures the adequacy of the study design and interpretations.

  • Time restriction can limit the possibility of recruiting the targeted sample size in the longitudinal study.

Introduction

Due to changes in the global population’s age structure, the prevalence of heart failure (HF) is rapidly increasing.1 It is estimated that 37.7 million people worldwide are affected by this health condition.2 It is associated with an increased mortality risk, substantial healthcare costs and major limitations in the patient’s quality of life.3 Therapy of HF usually begins with modification of the patients’ lifestyle and pharmacotherapy in order to prevent a progression of the disease and to maintain the heart’s functioning. If these approaches do not succeed and drug treatment options have been exhausted, heart transplantation is considered to be the therapeutic gold standard for advanced HF. However, this is not always possible, since the demand for donor hearts exceeds the availability and some patients are not eligible for heart transplantation.4 5 Meanwhile, there are alternatives due to the rapid development of medical technologies in recent decades.6 As such, left ventricular assist devices (LVADs) have become established in the treatment of advanced HF. In 2016, the annual amount of 965 LVAD implantations tripled 291 heart transplantations in Germany. LVADs are artificial blood pumps that can be implanted into the patient’s chest to normalise the circulation while it stays interconnected with extracorporeal controls and batteries by drivelines exiting at the abdomen.5 Initially, these devices were developed for short-term support in order to bridge critically ill patients to transplantation. By now, LVADs are predominantly used for destination therapy (DT) over extended periods of time.7 8 This technology has evolved significantly over the past two decades, with the most important milestone being the transition from pulsatile to continuous flow pumps. The latter are more durable and have significantly fewer complications. Thus, they are able to provide support over extended periods of up to 14 years.5 In the course of this development, psychosocial outcomes of LVAD therapy receive increasing attention in the scientific literature.3 4 7 Available studies highlight the potential of LVAD therapy for improving the patients’ quality of life and reducing severity of HF symptoms.9 10 Nevertheless, an LVAD also entails functional limitations as well as psychological burden for the patients and their social environment. Fear of complications such as strokes and the dependence of one’s life are permanently present because of the extracorporeal components.9–11 Those affected have to adjust to the situation of living with an LVAD.

Psychological adjustment to a chronic disease is commonly defined by presence or absence of psychological disorders, symptoms or distress, but it can also result in personal growth. Patients adjust to a health condition by dealing with disease-related challenges in various life domains under the influence of the disease progression and contextual factors. The extent to which patients master these challenges varies interindividually.12 This variation can be explained with the transactional model of stress and coping (TMSC) of Lazarus and Folkman.13 14 This is an established model in coping research and the conceptual basis of assessment instruments such as the Ways of Coping Questionnaire,15 Ways of Coping Checklist16 and the Perceived Stress Scale.17 Studies that used these instruments underline the model’s validity.18 19 The TMSC distinguishes between two processes, cognitive appraisal and coping (see figure 1). Cognitive appraisal consists of two phases. First, there is the primary appraisal in which a person evaluates if a stress encounter may be positive, harmful or irrelevant to one’s well-being. In case of a potentially harmful stress encounter, the secondary appraisal follows. The person evaluates which coping options are available, applicable and effective to overcome or prevent the potential harm. The primary and the secondary appraisal converge in an evaluation whether the situation is challenging, harmful or threatening. This is followed by the process of coping, in which the protagonist applies cognitive and behavioural efforts to cope with the stressful event using available resources. The changed relationship with the stressor is then reappraised and can lead to further coping efforts.15 20

Figure 1.

Figure 1

Transactional model of stress and coping (own illustration based on Folkman et al,15 Lazarus and Folkman14).

In order to investigate the psychological adaption and coping of patients with LVAD, Abshire et al conducted a meta-synthesis of seven qualitative studies published between 2007 and May 2015, that is also based on the TMSC. They identified four stages in the adaption process, of which each faces the patients with physical, psychological and social challenges: pre-LVAD, implant hospitalisation, early home adaptation and late home adaptation. The review also highlights a lack of research. The seven papers included are based on six relatively small samples of 5 to 12 patients, most of whom have had the LVAD for less than a year.21–23 Certain studies also included explanted patients24 25 or patients with pulsatile devices.26 However, recent studies highlight an improvement in the patients’ well-being despite substantial emotional distress and that a new normality establishes as a result of favourable coping processes requiring changes in one’s lifestyle and look on life.21 23–25 27 28 An influence of patient-related factors on psychological adjustment is also indicated, for example, social support is advocated as a facilitator.23 25 27 29 Clinical factors such as therapy strategy are relevant as well. For example, patients with LVAD expecting a heart transplant tend to experience living with an LVAD as living on standby.25

Rationale

LVAD therapy affects an increasing number of patients for prolonged periods and therefore psychosocial aspects of living with the device are gaining in relevance. This is particularly applicable for DT patients, who probably live with the LVAD for the rest of their lives. Present research shows that these patients live in a very complex and specific situation that entails psychological burden and challenges. Patients cope with these challenges in a process of psychological adjustment with varying outcomes using individually available strategies as well as personal and situational resources. Pertinent qualitative research is needed to gain a deeper understanding of psychological adjustment to living with an LVAD so that the situation of patients with LVAD can be adequately addressed in healthcare.

Objectives

This study aims to explore psychological burden and coping of patients under DT following LVAD implantation. Specifically, the cross-sectional investigation aims to describe coping strategies, related resources and barriers from the perspective of patients under DT living with the LVAD from a few weeks to more than 3 years. The longitudinal component aims to explore the course of psychological adjustment to living with an LVAD during the first year after implantation.

Methods and analysis

A qualitative approach will be adopted due to the explorative research focus. The study design comprises a cross-sectional and a longitudinal investigation. Cross-sectional in-depth interviews will be conducted with at least 18 DT patients. A subsample will be interviewed longitudinally for two additional times within the following year. The study is conceptually aligned with the TMSC,15 since it has shown to be adequate for examining coping processes of patients with various life-threatening diseases12 and of patients with LVAD30 in particular. Since there is no reporting guideline for qualitative study protocols, the present protocol is guided by the Consolidated criteria for Reporting Qualitative research (COREQ) checklist (see online supplemental appendix).31

Supplementary data

bmjopen-2020-037017supp001.pdf (111.4KB, pdf)

Sample and recruitment

All patients to be included in this study will be implanted with an LVAD, undergoing DT, at least 18 years old and fluent in German. Beyond this, no explicit exclusion criteria will be applied. For the cross-sectional study, we will purposefully sample for the elapsed time since implantation, because psychological adjustment and coping change over time.21 At least 18 patients will be included who spent varying time on LVAD support. We aim to include at least six patients, who live with the LVAD for a maximum of 3 months, 9–15 months and 3 years or longer (see figure 2). In order to recruit the subsample of patients who have the LVAD implanted for a maximum of 3 months, all patients who are implanted with an LVAD at the collaborating clinic from July 2019 to April 2020 will be asked for participation. Based on estimates provided by the clinicians, we expect to recruit nine recently implanted patients this way. These patients will also be asked to participate in two additional interviews for the longitudinal investigation. We aim to recruit about nine patients for the longitudinal component, because we expect a drop out of 25%. For this estimate, methodological literature,32–36 suggestions of affiliated physicians treating patients with LVAD and mortality of patients under DT based on a recent large scale study37 were taken into consideration.

Figure 2.

Figure 2

Survey and case number planning.

Further criteria for purposeful sampling are age, gender, cohabitation and whether the patients were able to decide on LVAD implantation themselves, since these factors are expected to be relevant for the coping process. Choices in participant selection are expected to be limited due to the small population size and the serious health condition of which the patients are affected. Therefore, we aim to include at least one patient per characteristic, so that varying perspectives are taken into account.34

Timing of the longitudinal studies will be based on key transitions in the course of disease and treatment in accordance with methodological literature for qualitative longitudinal studies on coping.35 Therefore, the phases identified by Abshire et al will be used and adapted to the German healthcare system.30

The sample will include at least 18 patients living with the LVAD for different lengths of time. This is to ensure a certain degree of variability and validity and to make the project manageable.33 34 However, the final sample size will depend on the amount of LVADs to be implanted during the time frame.

Participants will be recruited at a ventricular assist device (VAD) outpatient department by the treating physicians and VAD coordinators. They will inform eligible patients during their follow-up visits about the opportunity to participate in the study. Patients who are interested will be handed out preliminary study information and asked for written consent to arrange an appointment with the interviewer at the next outpatient visit. At this appointment the patient will be approached by the interviewer who comprehensively explains the study information and provides a copy. If the patients then consent, the interview will be conducted.

Various measures will be taken to promote the recruitment efforts and to prevent substantial dropout from the longitudinal study that goes beyond the natural attrition. The study will be conducted in close collaboration with the VAD outpatient clinic that is closely related to its patients. The patients come there for follow-up visits every 4–8 weeks. The interviews will be conducted as part of these obligatory visits during idle times. Thus, study participation will not require additional time or travel. When convenient, patients will also be interviewed during inpatient hospital stays.

Data collection

Data will be collected via semistructured face-to-face interviews. Some patients come to the outpatient visits by themselves and others are accompanied by caregivers. These patients can decide, whether the caregiver takes part in the interview. All patients will be interviewed by the same male researcher (ML), who is qualified in qualitative research and interview techniques. Each interview is expected to last 30–60 min. The interviewer will write a postscript immediately after conducting the interviews. In the postscripts first ideas for interpretation and situational, non-verbal or other outstanding features, will be retained.38 All interviews will be recorded digitally with a dictation device and transcribed afterwards. The interviewees will be offered the opportunity to check their respective transcripts.

The interviews will be based on an interview guide that was developed to address patients’ experiences on burdens, resources and coping behaviour as outlined in the TMSC. The according questions for the cross-sectional interviews are based on previous literature research and discussions with patients and practitioners (see box 1 and the Public and patient involvement section). All main questions will be addressed in each interview to ensure comparability. These ask for the perceptions of LVAD healthcare, for barriers and facilitators in everyday life with an LVAD, for key transition phases as identified by Abshire et al and for different aspects of the coping process as pointed out by the TMSC.14 The interview guide was pilot tested with one patient. The included questions serve as guidance, but also allow the interviewees to contribute their own topics and suggestions (eg, on ways to improve healthcare). Interview guides for the second and third longitudinal interview will be developed from preceding analysis of the first survey cycle. The structure of the main topics (participation, healthcare and coping) from the first interview guide will be retained, but the questions will more specifically address burdens, coping resources and behaviour identified to be relevant in the previous interviews.

Box 1. Interview guide (translated from German into English).

Living with a left ventricular assist device (LVAD)

  • I have a theoretical and technical understanding of how an LVAD works, but would like to know more about how it feels to live with it.

    Can you tell me what it is like to live with an LVAD?

Participation and healthcare

  • What areas of your everyday life does the LVAD affect?

    (If recreational activities are not discussed: How does the LVAD affect your recreational activities?)

  • What makes it easier or harder for you to deal with everyday challenges due to the LVAD?

  • Think about your hospital stay after implantation and the related healthcare, was there anything that made your situation easier or harder?

  • Was there anything in inpatient rehabilitation that made life with an LVAD easier or harder for you?

  • What has helped or made it more difficult for you to live with the LVAD since returning home?

  • Would you change anything in healthcare for patients with LVAD? If so, what would that be?

Burden, resources and coping

(Referring to the visual analogue scale on the questionnaire.): On this questionnaire you see a scale on the perceived stress level. Can you indicate your level of perceived stress on this scale with a cross?

  • What causes this burden?

    You indicated a low/medium/high perceived stress level due to the LVAD.(If no stress is indicated: You indicated that you feel no stress due to the LVAD. Is that correct?)

  • What has burdened you most in the course of LVAD therapy?

    (If no burden is mentioned, the following questions refer to psychological burdens after LVAD implantation in general.)

  • How do you cope with psychological burden due to the LVAD?

    To what extent has it changed how they felt ‘burden’? (Probing for emotion-oriented coping strategies.)

    To what extent have you done something to change the burdening situation? (Probing for problem-oriented coping strategies.)

  • What has helped you in dealing with psychological burden due to the LVAD?

    Which of your personality traits have helped you in dealing with psychological burden? (Probing for personal resources.)

    What factors in your personal environment have helped you in dealing with the psychological burden? (Probing for situational resources.)

  • If you look back on the entire time span since the implantation of the LVAD, how has the way in which you experience psychological burden through the LVAD changed?

Ending

  • Is there anything you have not said yet that would be of interest to the study?

Main questions=bold.

Interviewees will also be asked to complete the German version of the TMSC-based Perceived Stress Scale (PSS).17 39In addition, they will receive a short questionnaire that asks for age, gender, marital status, cohabitation, education, occupational status, device type, perceived stress level (on a visual analogue scale), ability to decide on implantation, date of implantation and HF onset. This quantitative data will be used to describe sample characteristics with relevance for psychological burden and coping. The PSS will also be used in the longitudinal interviews to monitor the perceived stress level over time on a descriptive level.

Data analysis

The data collected with the questionnaires will be analysed descriptively using the statistics software SPSS V.24.40 The audio recordings of the interviews will be transcribed using the software f4transkript,41 following transcription rules that have been adapted from McLellan et al and Kuckartz.42 43 Since the analyses focus on manifest contents, dialects and fillers are not transcribed. The transcripts will then be anonymised and imported into the qualitative data analysis software MAXQDA.44 For quality assurance, all recordings and transcripts are cross-checked by at least two persons. As a form of triangulation and to ensure intersubjective validity, at least two researchers are involved in each step of analysis.45 Key decisions in the analyses will be discussed and consented with three or more researchers.

Cross-sectional interviews

An inductive qualitative content analysis as outlined by Elo and Kyngas will be carried out46 47 to explore coping strategies, related resources and barriers from the perspective of DT patients living with the LVAD. Manifest contents in interview texts about coping with psychological burden after LVAD implantation and related resources or barriers will be the unit of analysis. The analysis will follow six steps, which are adapted from pertinent methodological literature45 46 48:

  1. Familiarising with the data: two coders familiarise themselves with the data by reading the transcripts. Six interviews that differ in content as far as possible will be selected for the first three steps of analysis. Both coders read the six interviews and extract single meaning units (sequence of content or context-related words) about coping with psychological burden after LVAD implantation from the interview texts.

  2. Open coding: the extracts will be subjected to an inductive open coding which is conducted independently by the two coders. Every meaning unit will be labelled with a code. This process is oriented to explore burdens, resources and coping behaviour according to the TMSC. The developed codes are then checked for consistency and refined. As many codes as necessary to label all relevant meaning units will be developed.

  3. Grouping: the codes of both coders will be compared and similar codes will be merged. The codes are then grouped under higher order headings and linked to each other in a hierarchical coding system. Adequacy of the coding system will then be tested against three further interviews by both coders.

  4. Coding all data: the coding system will be applied to all further interviews by one coder. If there are further relevant meaning units that cannot be classified in the existing system, new codes will be developed and added.

  5. Categorisation: a category system comprising generic categories with subcategories (in terms of Elo and Kyngas46 will be developed from the coding system. Each generic category will be described in a memo with its subcategories. The generic categories are then contrasted against each other and refined. The category system is considered to be finalised when no extracted meaning units fall between two categories or fit in more than one.45 This state will be ascertained by three researchers.

  6. Abstraction: main categories on the highest level of abstraction are developed from the category system. The findings will then be translated into the TMSC as the theoretical framework. Thus, a TMSC-based model will be developed from the data that describes coping of patients with LVAD with related strains, resources and barriers. The final interpretation will be consented with all researchers involved.

Longitudinal interviews

The analysis of the longitudinal interviews aims to explore psychological adjustment to living with an LVAD during the first year after implantation using a deductive content analysis as outlined by Elo and Kyngas.46 The structure for this analysis will be operationalised based on the findings of the previously analysed cross-sectional interviews. The following steps for a deductive content analysis will be applied to the interviews of T2 and T3 separately.46 The cross-sectional and longitudinal interviews will be analysed by the same researchers, who are already familiar with the data.

  1. Extraction: two researchers read the interviews of the interview cycle and extract relevant meaning units from the patient’s statements in the transcripts. All meaning units considered to be relevant by one researcher will be included in the analysis.

  2. Developing a categorisation matrix: based on the model that was developed in the preceding inductive content analysis, a categorisation matrix comprising its main themes will be developed by one researcher and then discussed with the three researchers.

  3. Categorisation: the extracted meaning units will be assigned to the categorisation matrix by both researchers. The codings will then be discussed and consented by both researchers. If the two researchers disagree, a third researcher will be consulted.

  4. Extending the categorisation matrix: unassigned meaning units will be aggregated and checked for relevant contents that are not represented in the matrix. If both coders agree, new categories will be developed based on the principles of inductive content analysis. The final categorisation matrix maps the process of psychological adjustment over the first year after an LVAD implantation.

The results of the analyses can help to critically evaluate current healthcare practice and to support patients more adequately in coping with the emerging challenges. While the study focus is on patients under DT in Germany, insights can partly be applicable to patients with LVAD in other countries or and with other dependable medical devices.

Patient and public involvement

Patients and healthcare practitioners are involved at different stages of the research process. Reporting is based on the Guidance for Reporting Involvement of Patients and the Public (GRIPP2) short form (online supplemental appendix).49

Patient and practitioner involvement during study preparation aimed to ensure adequacy of methodology and study information, reasonableness of the interviews and consideration of all relevant aspects in the interview guide. During initial study planning, the research question was developed in collaboration with a physician experienced in LVAD healthcare. Two further physicians, two VAD coordinators and two patients were consulted in individual meetings for developing the study design. This has been beneficial to develop a comprehensive understanding of the actual healthcare situation and to get a clear impression of the patient group. Based on their feedback, various specific changes were made: a more structured interview technique was chosen, which was considered to be more appropriate for the patient group; the criterion whether a patient was able to decide on the LVAD implantation was adopted for purposeful sampling; the question about recreational activities was added to the interview guide.

Patients and practitioners will be involved in the analysis to ensure validity of interpretations and to explore ways for disseminating the results to patients. Therefore, a preliminary category system will be discussed with a practitioner and a patient as part of the inductive content analysis after grouping the codes (third step of analysis). The results of the inductive content analysis and preliminary results of the deductive content analysis will also be discussed with patients at a self-help group meeting.

Ethics and dissemination

The study obtained ethical approval from the ethics committee of the School of Medicine and Health Sciences at the University of Oldenburg (2019-023).

Although the study is non-interventional, talking about consequences of the LVAD implantation could affect the patients’ psychological well-being. The participants will be fully informed about this and further potential risks as part of the study information. In order to prevent harmful consequences, various measures are taken. The interviews are conducted in the clinic, which is familiar to the patients. Accordingly, psychological support by the clinic staff is available when needed and the interviewer himself is experienced in dealing with vulnerable groups. In addition, interview contents and setting were discussed with patients and practitioners to ensure reasonableness. The patients’ voluntary participation can be revoked at any time without stating any reason.

The data will be deposited at the University of Oldenburg and processed according to data management and security requirements of the applicable data protection regulations, particularly the General Data Protection Regulation (EU) 2016/679. The anonymised results of this study will be published in scientific journals and presented at national and international conferences.

Study status

Recruitment for the study started in October 2019 and will continue until April 2020. For the cross-sectional investigation data, collection will presumably continue until April 2020. For the longitudinal study, data collection is expected to take until April 2021.

Supplementary Material

Reviewer comments
Author's manuscript

Acknowledgments

We would like to thank the patients, healthcare professionals and especially Professor Reiss for contributing their knowledge and experiences to the study design.

Footnotes

Contributors: ML and ALB conceived the study with guidance and feedback from HCE and SM. All authors read and approved the final manuscript.

Funding: This study is financed from resources of the University of Oldenburg that were endowed by Deutsche Rentenversicherung (German pension insurance) Oldenburg-Bremen for establishment of the junior research group for rehabilitation sciences.

Competing interests: None declared.

Patient consent for publication: Not required.

Provenance and peer review: Not commissioned; externally peer reviewed.

Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

References

  • 1.GBD 2015 Mortality and Causes of Death Collaborators Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015. Lancet 2016;388:1459–544. 10.1016/S0140-6736(16)31012-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol 2016;13:368–78. 10.1038/nrcardio.2016.25 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Grady KL, Warner Stevenson L, Pagani FD, et al. Beyond survival: recommendations from INTERMACS for assessing function and quality of life with mechanical circulatory support. J Heart Lung Transplant 2012;31:1158–64. 10.1016/j.healun.2012.08.020 [DOI] [PubMed] [Google Scholar]
  • 4.Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241–51. 10.1056/NEJMoa0909938 [DOI] [PubMed] [Google Scholar]
  • 5.Willemsen D, Cordes C, Bjarnason-Wehrens B, et al. [Rehabilitation standards for follow-up treatment and rehabilitation of patients with ventricular assist device (VAD)]. Clin Res Cardiol Suppl 2016;11 Suppl 1:2–49. 10.1007/s11789-015-0077-x [DOI] [PubMed] [Google Scholar]
  • 6.Sacks CA, Jarcho JA, Curfman GD. Paradigm shifts in heart-failure therapy--a timeline. N Engl J Med 2014;371:989–91. 10.1056/NEJMp1410241 [DOI] [PubMed] [Google Scholar]
  • 7.Maciver J, Ross HJ. Quality of life and left ventricular assist device support. Circulation 2012;126:866–74. 10.1161/CIRCULATIONAHA.111.040279 [DOI] [PubMed] [Google Scholar]
  • 8.Kirklin JK, Xie R, Cowger J, et al. Second annual report from the ISHLT mechanically assisted circulatory support registry. J Heart Lung Transplant 2018;37:685–91. 10.1016/j.healun.2018.01.1294 [DOI] [PubMed] [Google Scholar]
  • 9.Brouwers C, Denollet J, de Jonge N, et al. Patient-Reported outcomes in left ventricular assist device therapy: a systematic review and recommendations for clinical research and practice. Circ Heart Fail 2011;4:714–23. 10.1161/CIRCHEARTFAILURE.111.962472 [DOI] [PubMed] [Google Scholar]
  • 10.Adams EE, Wrightson ML. Quality of life with an LVAD: a misunderstood concept. Heart Lung 2018;47:177–83. 10.1016/j.hrtlng.2018.02.003 [DOI] [PubMed] [Google Scholar]
  • 11.Tigges-Limmer K, Brocks Y, Winkler Y, et al. Psychosocial aspects in the diagnostics and treatment of LVAD patients. living on device as borderline experiences according to Jaspers. Z Herz Thorax Gefass 2018;32:141–9. [Google Scholar]
  • 12.Stanton AL, Revenson TA, Tennen H. Health psychology: psychological adjustment to chronic disease. Annu Rev Psychol 2007;58:565–92. 10.1146/annurev.psych.58.110405.085615 [DOI] [PubMed] [Google Scholar]
  • 13.Felton BJ, Revenson TA, Hinrichsen GA. Stress and coping in the explanation of psychological adjustment among chronically ill adults. Soc Sci Med 1984;18:889–98. 10.1016/0277-9536(84)90158-8 [DOI] [PubMed] [Google Scholar]
  • 14.Lazarus RS, Folkman S. Transactional theory and research on emotions and coping. Eur J Pers 1987;1:141–69. 10.1002/per.2410010304 [DOI] [Google Scholar]
  • 15.Folkman S, Lazarus RS, Dunkel-Schetter C, et al. Dynamics of a stressful encounter: cognitive appraisal, coping, and encounter outcomes. J Pers Soc Psychol 1986;50:992–1003. 10.1037/0022-3514.50.5.992 [DOI] [PubMed] [Google Scholar]
  • 16.Vitaliano PP, Russo J, Carr JE, et al. The ways of coping checklist: revision and psychometric properties. Multivariate Behav Res 1985;20:3–26. 10.1207/s15327906mbr2001_1 [DOI] [PubMed] [Google Scholar]
  • 17.Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385–96. 10.2307/2136404 [DOI] [PubMed] [Google Scholar]
  • 18.Cheng C, Lau H-PB, Chan M-PS. Coping flexibility and psychological adjustment to stressful life changes: a meta-analytic review. Psychol Bull 2014;140:1582–607. 10.1037/a0037913 [DOI] [PubMed] [Google Scholar]
  • 19.Penley JA, Tomaka J, Wiebe JS. The association of coping to physical and psychological health outcomes: a meta-analytic review. J Behav Med 2002;25:551–603. 10.1023/A:1020641400589 [DOI] [PubMed] [Google Scholar]
  • 20.Folkman S, Lazarus RS. An analysis of coping in a middle-aged community sample. J Health Soc Behav 1980;21:219–39. 10.2307/2136617 [DOI] [PubMed] [Google Scholar]
  • 21.Casida JM, Marcuccilli L, Peters RM, et al. Lifestyle adjustments of adults with long-term implantable left ventricular assist devices: a phenomenologic inquiry. Heart Lung 2011;40:511–20. 10.1016/j.hrtlng.2011.05.002 [DOI] [PubMed] [Google Scholar]
  • 22.Marcuccilli L, Casida JJ, Peters RM, et al. Sex and intimacy among patients with implantable left-ventricular assist devices. J Cardiovasc Nurs 2011;26:504–11. 10.1097/JCN.0b013e31820e2fae [DOI] [PubMed] [Google Scholar]
  • 23.Sandau KE, Hoglund BA, Weaver CE, et al. A conceptual definition of quality of life with a left ventricular assist device: results from a qualitative study. Heart Lung 2014;43:32–40. 10.1016/j.hrtlng.2013.09.004 [DOI] [PubMed] [Google Scholar]
  • 24.Hallas C, Banner NR, Wray J. A qualitative study of the psychological experience of patients during and after mechanical cardiac support. J Cardiovasc Nurs 2009;24:31–9. 10.1097/01.JCN.0000317472.65671.e2 [DOI] [PubMed] [Google Scholar]
  • 25.Overgaard D, Grufstedt Kjeldgaard H, Egerod I. Life in transition: a qualitative study of the illness experience and vocational adjustment of patients with left ventricular assist device. J Cardiovasc Nurs 2012;27:394–402. 10.1097/JCN.0b013e318227f119 [DOI] [PubMed] [Google Scholar]
  • 26.Chapman E, Parameshwar J, Jenkins D, et al. Psychosocial issues for patients with ventricular assist devices: a qualitative pilot study. Am J Crit Care 2007;16:72–81. 10.4037/ajcc2007.16.1.72 [DOI] [PubMed] [Google Scholar]
  • 27.Modica M, Ferratini M, Torri A, et al. Quality of life and emotional distress early after left ventricular assist device implant: a mixed-method study. Artif Organs 2015;39:220–7. 10.1111/aor.12362 [DOI] [PubMed] [Google Scholar]
  • 28.Bidwell JT, Lyons KS, Mudd JO, et al. Patient and caregiver determinants of patient quality of life and caregiver strain in left ventricular assist device therapy. J Am Heart Assoc 2018;7:008080. 10.1161/JAHA.117.008080 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Rhoades BD, Beauchamp JES, Engebretson JC, et al. Influencing factors on left ventricular assist device adaptation: a systematic review. Heart Lung 2020;49:501–11. 10.1016/j.hrtlng.2020.01.015 [DOI] [PubMed] [Google Scholar]
  • 30.Abshire M, Prichard R, Cajita M, et al. Adaptation and coping in patients living with an LVAD: a metasynthesis. Heart Lung 2016;45:397–405. 10.1016/j.hrtlng.2016.05.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007;19:349–57. 10.1093/intqhc/mzm042 [DOI] [PubMed] [Google Scholar]
  • 32.Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res 2015. [DOI] [PubMed] [Google Scholar]
  • 33.Morse JM. Determining sample size. Qual Health Res 2000;10:3–5. 10.1177/104973200129118183 [DOI] [Google Scholar]
  • 34.Sandelowski M. Sample size in qualitative research. Res Nurs Health 1995;18:179–83. 10.1002/nur.4770180211 [DOI] [PubMed] [Google Scholar]
  • 35.Calman L, Brunton L, Molassiotis A. Developing longitudinal qualitative designs: lessons learned and recommendations for health services research. BMC Med Res Methodol 2013;13:14. 10.1186/1471-2288-13-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Murray SA, Kendall M, Carduff E, et al. Use of serial qualitative interviews to understand patients' evolving experiences and needs. BMJ 2009;339:b3702. 10.1136/bmj.b3702 [DOI] [PubMed] [Google Scholar]
  • 37.Jorde UP, Kushwaha SS, Tatooles AJ, et al. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for mechanically assisted circulatory support). J Am Coll Cardiol 2014;63:1751–7. 10.1016/j.jacc.2014.01.053 [DOI] [PubMed] [Google Scholar]
  • 38.Witzel A. Das problemzentrierte interview.Forum qualitative Sozialforschung. 1, 2000. [Google Scholar]
  • 39.Klein EM, Brähler E, Dreier M, et al. The German version of the Perceived Stress Scale - psychometric characteristics in a representative German community sample. BMC Psychiatry 2016;16:159. 10.1186/s12888-016-0875-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.IBM SPSS statistics for windows, version 24.0. computer program. New York: IBM Corp, 2016. [Google Scholar]
  • 41.f4transkript f4transkript (Version 7) [computer program]. Marburg, Germany: dr dresing & pehl GmbH, 2018. [Google Scholar]
  • 42.McLellan E, MacQueen KM, Neidig JL. Beyond the qualitative interview: data preparation and transcription. Field methods 2003;15:63–84. 10.1177/1525822X02239573 [DOI] [Google Scholar]
  • 43.Kuckartz U. Qualitative Inhaltsanalyse : Methoden, Praxis, Computerunterstützung. Weinheim Beltz Juventa, 2016. [Google Scholar]
  • 44.MAXQDA Software for qualitative data analysis 1989-2019 [computer program]. Berlin, Germany: VERBI Software.Sozialforschung GmbH, 2019. [Google Scholar]
  • 45.Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today 2004;24:105–12. 10.1016/j.nedt.2003.10.001 [DOI] [PubMed] [Google Scholar]
  • 46.Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs 2008;62:107–15. 10.1111/j.1365-2648.2007.04569.x [DOI] [PubMed] [Google Scholar]
  • 47.Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci 2013;15:398–405. 10.1111/nhs.12048 [DOI] [PubMed] [Google Scholar]
  • 48.Bengtsson M. How to plan and perform a qualitative study using content analysis. NursingPlus Open 2016;2:8–14. 10.1016/j.npls.2016.01.001 [DOI] [Google Scholar]
  • 49.Staniszewska S, Brett J, Simera I, et al. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ 2017;358:j3453. 10.1136/bmj.j3453 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data

bmjopen-2020-037017supp001.pdf (111.4KB, pdf)

Reviewer comments
Author's manuscript

Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES